Journals / Fırat Üniversitesi Sağlık Bilimleri Tıp Dergisi / 2021 / Cilt: 35 - Sayı: 1

Is There a Correlation Between the Breast FibroglandularTissue Thickness Ratio and Mastalgia Severity in Patientswith Cyclic Mastalgia?

Siklik Mastaljili Hastalarda Meme Fibroglandüler Doku Kalınlığı Oranı ile Mastalji Şiddeti Arasında Bir Korelasyon Var mı?

Pages
16–19
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A more effective analgesictreatment approach and a more careful follow-up in terms of cancer should be applied to patientswith high breast density.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The purpose of this study is to evaluate correlation between the breast fibroglandulartissue thickness ratio and mastalgia severity in patients with cyclic mastalgia.
📊
Key Findings & Data:Results: The patients’ ages were between 18 and 39 with a mean age of 30.1.
💡
Conclusion & Impact:A more effective analgesictreatment approach and a more careful follow-up in terms of cancer should be applied to patientswith high breast density.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The purpose of this study is to evaluate correlation between the breast fibroglandulartissue thickness ratio and mastalgia severity in patients with cyclic mastalgia. Materials and Methods: Ninety-six women with mastalgia in premenopausal reproductive agewere prospectively evaluated. All patients were evaluated by the same general surgeon andseverity of mastalgia was assessed by using visual analogue scale (VAS). Breast fibroglandulartissue thickness ratio was defined as the ratio of fibroglandular tissue thickness to distancebetween skin and anterior chest wall muscles. These measurements were made in the periareolarareas in the upper-outer quadrants of both breasts with ultrasound. Pearson correlation coefficienttest was used for statistical analysis. Results: The patients’ ages were between 18 and 39 with a mean age of 30.1. The meanfibroglandular tissue thickness ratio of the whole group was 0.618 mm. The Pearson’s coefficient rvalue for the correlation between the mean breast fibroglandular tissue ratio and VAS scores was0.791, which means that there is strong correlation. While we categorized patients in 3 groups ashaving mild, moderate and severe mastalgia The Pearson’s coefficient r value for correlationbetween the mean breast fibroglandular tissue ratio and severity groups is 0.737. Conclusion: In our study we found that the mean breast fibroglandular tissue ratio is stronglycorrelated with mastalgia severity in patients with cyclic mastalgia. A more effective analgesictreatment approach and a more careful follow-up in terms of cancer should be applied to patientswith high breast density.

Özet

Amaç: Bu çalışmanın amacı siklik mastaljili hastalarda meme fibroglandüler doku kalınlığı oranı ilemastalji şiddeti arasındaki ilişkiyi değerlendirmektir. Gereç ve Yöntem: Mastalji şikayeti premenepozal üreme çağındaki 96 kadın prospektif olarakdeğerlendirildi. Hastalar aynı genel cerrah tarafından muayene edildi ve mastalji şiddeti görselanalog skala (VAS) ile değerlendirildi. Meme fibroglandüler doku kalınlığı oranı, fibroglandüler dokukalınlığının deri ve ön göğüs duvarı kasları arasındaki mesafeye oranı olarak tanımlandı. Buölçümler, her iki memenin üst-dış kadranındaki periareolar alanlarda ultrasound ile yapıldı.İstatistiksel analizde Pearson korelasyon katsayısı testi kullanıldı. Bulgular: Hastaların yaşları 18 ile 39 arasındaydı ve ortalama yaş 30.1 idi. Tüm grubun ortalamafibroglandüler doku kalınlığı oranı 0.618 mm idi. Ortalama meme fibroglandüler doku oranı ile VASskorları arasındaki korelasyon için Pearson'ın katsayısı r değeri 0.791 idi, bu da güçlü birkorelasyon olduğu anlamına gelir. Hastaları hafif, orta ve şiddetli olarak 3 grupta kategorizeederken ortalama meme fibroglandüler doku oranı ve şiddet grupları arasındaki korelasyon içinPearson'ın katsayısı r değeri 0.737'dir. Sonuç: Çalışmamızda, siklik mastaljili hastalarda ortalama meme fibroglandüler doku oranınınmastalji şiddeti ile güçlü bir şekilde ilişkili olduğunu bulduk. Meme yoğunluğu yüksek olan hastalaradaha etkili bir analjezik tedavi yaklaşımı ve kanser açısından daha dikkatli bir takip uygulanmalıdır.

🔖

Cite This Article

BOZDAĞ, A., ERKUŞ, F., BİRKAN, Z., DEMİRKAZIK, F. B. (2022). Is There a Correlation Between the Breast FibroglandularTissue Thickness Ratio and Mastalgia Severity in Patientswith Cyclic Mastalgia?. Fırat Üniversitesi Sağlık Bilimleri Tıp Dergisi, Cilt: 35 - Sayı: 1, 16–19. https://ajindex.com/articles/514399

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Ferrara A. Benign breast disease. Radiol Technol 2011; 82: 447-462
  2. Idiz C, Cakir C, Ulusoy AI, Idiz UO. The role of nutrition in women with benign cyclic mastalgia: A case-control study. Eur J Breast Health 2018; 14: 156-159
  3. Jokich PM, Bailey L, D'Orsi C, et al. ACR Appropriateness criteria® breast pain. J Am Coll Radiol 2017; 14: 25-33
  4. Scurr J, Hedger W, Morris P, Brown N. The prevalence, severity, and impact of breast pain in the general population. Breast J 2014; 20: 508-513
  5. Arslan M, Kucukerdem HS, Can H, Tarcan E. Retrospective analysis of women with only mastalgia. J Breast Health 2016; 12: 151-154
  6. Ader DN, Browne MW. Prevalence and impact of cyclic mastalgia in a United States clinic-based sample. Am J Obstet Gynecol 1997; 177: 126-132
  7. Smith RL, Pruthi S, Fitzpatrick LA. Evaluation and management of breast pain. Mayo Clin Proc 2004; 79: 353-372
  8. Brown N, Burnett E, Scurr J. Is Breast Pain Greater in Active Females Compared to the General Population in the UK? Breast J 2016; 22: 194-201
  9. Iddon J. ABC of breast disease, 3rd ed. Edinburgh, Blackwell Publishing, 2006, 15-18
  10. Leung JW, Korguth PJ, Gotway MB: Utility of targeted sonography in the evaluation of focal breast pain. J Ultrasound Med 2002; 21: 521-526
  11. Miltenburg DM, Speights VO Jr. Benign breast disease. Obstet Gynecol Clin North Am 2008; 35: 285-300
  12. Rathi J, Chawla I, Singh K, Chawla A. Centchroman as first-line treatment for mastalgia: Results of an open-label, single-arm trial. Breast J 2016; 22: 407- 412
  13. Dhar A, Srivastava A. Role of centchroman in regression of mastalgia and fibroadenoma. World J Surg 2007; 31: 1178-1184
  14. Groen JW, Grosfeld S, Wilschut JA, et al. Cyclic and noncyclic breast-pain: A systematic review on pain reduction, side effects, and quality of life for various treatments. Eur J Obstet Gynecol Reprod Biol 2017; 219: 74-93
  15. Kanat BH, Atmaca M, Girgin M, et al. Effects of mastalgia in young women on quality of life, depression, and anxiety levels. Indian J Surg 2016; 78: 96-99
  16. Goodwin PJ, DeBoer G, Clark RM, et al. Cyclical mastopathy and premenopausal breast cancer risk. Results of a case-control study. Breast Cancer Res Treat 1995; 33: 63-73
  17. Plu-Bureau G, Thalabard JC, Sitruk-Ware R, Asselain B, Mauvais-Jarvis P. Cyclical mastalgia as a marker of breast cancer susceptibility: results of a case-control study among French women. Br J Cancer 1992; 65: 945- 949
  18. Duijm LE, Guit GL, Hendriks JH, Zaat J